Multivalent peptoid conjugates which overcome enzalutamide resistance in prostate cancer cells
GO improved in 61% of patients treated with selenium and in 36% of patients receiving placebo, whereas the eye disease worsened in 7 and 26% of patients in the selenium and placebo group, respectively ( Figure 2 )
No clinical trial has linked BPC-157 to insomnia, but its documented effects on dopamine D2 and serotonin pathways provide a plausible mechanism for sleep disruption (Sikiri et al., J Physiol Paris, 1999)
* Crosses the Blood-Brain Barrier - ALC is a form of L-carnitine, an amino acid derivative that helps the body produce energy
Over the years, it has become increasingly evident that maintaining a stable intestinal barrier is crucial to prevent various potentially harmful substances and pathogens from entering the internal environment
Oxidative stress and autoimmune thyroid disease